Cargando…

Effect and Comparison of Luteolin and Its Derivative Sodium Luteolin-4′-sulfonate on Adipogenic Differentiation of Human Bone Marrow-Derived Mesenchymal Stem Cells through AMPK-Mediated PPARγ Signaling

Luteolin is a common phytochemical from the flavonoid family with a flavone structure. Studies reported several bioactivities for luteolin and similar flavones. Attenuating the increased adipogenesis of bone marrow cells (hBM-MSCs) has been regarded as a therapeutic target against osteoporotic bone...

Descripción completa

Detalles Bibliográficos
Autores principales: Oh, Jung Hwan, Karadeniz, Fatih, Lee, Jung Im, Seo, Youngwan, Jang, Mi-Soon, Kong, Chang-Suk
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7644305/
https://www.ncbi.nlm.nih.gov/pubmed/33178328
http://dx.doi.org/10.1155/2020/8894910
_version_ 1783606426189430784
author Oh, Jung Hwan
Karadeniz, Fatih
Lee, Jung Im
Seo, Youngwan
Jang, Mi-Soon
Kong, Chang-Suk
author_facet Oh, Jung Hwan
Karadeniz, Fatih
Lee, Jung Im
Seo, Youngwan
Jang, Mi-Soon
Kong, Chang-Suk
author_sort Oh, Jung Hwan
collection PubMed
description Luteolin is a common phytochemical from the flavonoid family with a flavone structure. Studies reported several bioactivities for luteolin and similar flavones. Attenuating the increased adipogenesis of bone marrow cells (hBM-MSCs) has been regarded as a therapeutic target against osteoporotic bone disorders. In the present study, the potential roles of luteolin and its sulfonic acid derivative luteolin-OSO(3)Na in regulating adipogenic differentiation of hBM-MSCs were investigated. Adipo-induced cells were treated with or without compounds, and their effect on adipogenesis was evaluated by adipogenic marker levels such as lipid accumulation and PPARγ pathway activation. Luteolin hindered the adipogenic lipid accumulation in adipo-induced hBM-MSCs. Immunoblotting and reverse transcription-polymerase chain reaction analysis results indicated that luteolin downregulated PPARγ and downstream factors of C/EBPα and SREBP1c expression which resulted in inhibition of adipogenesis. Luteolin-OSO(3)Na showed similar effects; however, it was significantly less effective compared to luteolin. Investigating p38, JNK, and ERK MAPKs and AMPK activation indicated that luteolin suppressed the MAPK phosphorylation while stimulating AMPK phosphorylation. On the other hand, luteolin-OSO(3)Na was not able to notably affect the MAPK and AMPK activation. In conclusion, this study suggested that luteolin inhibited adipogenic differentiation of hBM-MSCs via upregulating AMPK activation. Replacing its 4′-hydroxyl group with sulfonic acid sodium salt diminished its antiadipogenic effect indicating its role in regulating AMPK activation. The general significance is that luteolin is a common phytochemical with various health-beneficial effects. The current study suggested that luteolin may serve as a lead compound for developing antiosteoporotic substances with antiadipogenic properties.
format Online
Article
Text
id pubmed-7644305
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-76443052020-11-10 Effect and Comparison of Luteolin and Its Derivative Sodium Luteolin-4′-sulfonate on Adipogenic Differentiation of Human Bone Marrow-Derived Mesenchymal Stem Cells through AMPK-Mediated PPARγ Signaling Oh, Jung Hwan Karadeniz, Fatih Lee, Jung Im Seo, Youngwan Jang, Mi-Soon Kong, Chang-Suk Evid Based Complement Alternat Med Research Article Luteolin is a common phytochemical from the flavonoid family with a flavone structure. Studies reported several bioactivities for luteolin and similar flavones. Attenuating the increased adipogenesis of bone marrow cells (hBM-MSCs) has been regarded as a therapeutic target against osteoporotic bone disorders. In the present study, the potential roles of luteolin and its sulfonic acid derivative luteolin-OSO(3)Na in regulating adipogenic differentiation of hBM-MSCs were investigated. Adipo-induced cells were treated with or without compounds, and their effect on adipogenesis was evaluated by adipogenic marker levels such as lipid accumulation and PPARγ pathway activation. Luteolin hindered the adipogenic lipid accumulation in adipo-induced hBM-MSCs. Immunoblotting and reverse transcription-polymerase chain reaction analysis results indicated that luteolin downregulated PPARγ and downstream factors of C/EBPα and SREBP1c expression which resulted in inhibition of adipogenesis. Luteolin-OSO(3)Na showed similar effects; however, it was significantly less effective compared to luteolin. Investigating p38, JNK, and ERK MAPKs and AMPK activation indicated that luteolin suppressed the MAPK phosphorylation while stimulating AMPK phosphorylation. On the other hand, luteolin-OSO(3)Na was not able to notably affect the MAPK and AMPK activation. In conclusion, this study suggested that luteolin inhibited adipogenic differentiation of hBM-MSCs via upregulating AMPK activation. Replacing its 4′-hydroxyl group with sulfonic acid sodium salt diminished its antiadipogenic effect indicating its role in regulating AMPK activation. The general significance is that luteolin is a common phytochemical with various health-beneficial effects. The current study suggested that luteolin may serve as a lead compound for developing antiosteoporotic substances with antiadipogenic properties. Hindawi 2020-10-29 /pmc/articles/PMC7644305/ /pubmed/33178328 http://dx.doi.org/10.1155/2020/8894910 Text en Copyright © 2020 Jung Hwan Oh et al. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Oh, Jung Hwan
Karadeniz, Fatih
Lee, Jung Im
Seo, Youngwan
Jang, Mi-Soon
Kong, Chang-Suk
Effect and Comparison of Luteolin and Its Derivative Sodium Luteolin-4′-sulfonate on Adipogenic Differentiation of Human Bone Marrow-Derived Mesenchymal Stem Cells through AMPK-Mediated PPARγ Signaling
title Effect and Comparison of Luteolin and Its Derivative Sodium Luteolin-4′-sulfonate on Adipogenic Differentiation of Human Bone Marrow-Derived Mesenchymal Stem Cells through AMPK-Mediated PPARγ Signaling
title_full Effect and Comparison of Luteolin and Its Derivative Sodium Luteolin-4′-sulfonate on Adipogenic Differentiation of Human Bone Marrow-Derived Mesenchymal Stem Cells through AMPK-Mediated PPARγ Signaling
title_fullStr Effect and Comparison of Luteolin and Its Derivative Sodium Luteolin-4′-sulfonate on Adipogenic Differentiation of Human Bone Marrow-Derived Mesenchymal Stem Cells through AMPK-Mediated PPARγ Signaling
title_full_unstemmed Effect and Comparison of Luteolin and Its Derivative Sodium Luteolin-4′-sulfonate on Adipogenic Differentiation of Human Bone Marrow-Derived Mesenchymal Stem Cells through AMPK-Mediated PPARγ Signaling
title_short Effect and Comparison of Luteolin and Its Derivative Sodium Luteolin-4′-sulfonate on Adipogenic Differentiation of Human Bone Marrow-Derived Mesenchymal Stem Cells through AMPK-Mediated PPARγ Signaling
title_sort effect and comparison of luteolin and its derivative sodium luteolin-4′-sulfonate on adipogenic differentiation of human bone marrow-derived mesenchymal stem cells through ampk-mediated pparγ signaling
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7644305/
https://www.ncbi.nlm.nih.gov/pubmed/33178328
http://dx.doi.org/10.1155/2020/8894910
work_keys_str_mv AT ohjunghwan effectandcomparisonofluteolinanditsderivativesodiumluteolin4sulfonateonadipogenicdifferentiationofhumanbonemarrowderivedmesenchymalstemcellsthroughampkmediatedppargsignaling
AT karadenizfatih effectandcomparisonofluteolinanditsderivativesodiumluteolin4sulfonateonadipogenicdifferentiationofhumanbonemarrowderivedmesenchymalstemcellsthroughampkmediatedppargsignaling
AT leejungim effectandcomparisonofluteolinanditsderivativesodiumluteolin4sulfonateonadipogenicdifferentiationofhumanbonemarrowderivedmesenchymalstemcellsthroughampkmediatedppargsignaling
AT seoyoungwan effectandcomparisonofluteolinanditsderivativesodiumluteolin4sulfonateonadipogenicdifferentiationofhumanbonemarrowderivedmesenchymalstemcellsthroughampkmediatedppargsignaling
AT jangmisoon effectandcomparisonofluteolinanditsderivativesodiumluteolin4sulfonateonadipogenicdifferentiationofhumanbonemarrowderivedmesenchymalstemcellsthroughampkmediatedppargsignaling
AT kongchangsuk effectandcomparisonofluteolinanditsderivativesodiumluteolin4sulfonateonadipogenicdifferentiationofhumanbonemarrowderivedmesenchymalstemcellsthroughampkmediatedppargsignaling